Transformation 2.0: The GLP-1 RAs as Psychiatric Medications?
Psychiatric Times
JULY 7, 2025
30-32 An investigation by the FDA, European Medicines Agency, and the United Kingdom’s Medicines and Healthcare Products Regulatory Agency concluded that current evidence does not support a causal link between GLP-1 RAs and suicidality. Download Issue PDF Articles in this issue Transformation 2.0: Expert Opin Drug Saf.
Let's personalize your content